Preoperative transarterial chemoembolization does not improve the outcomes of resectable hepatocellular carcinoma: A propensity score-matched study

Preoperative transarterial chemoembolization does not improve the outcomes of resectable hepatocellular carcinoma: A propensity score-matched study

Background: Transarterial chemoembolization (TACE) is reserved for the treatment of intermediate hepatocellular carcinoma (HCC) (Barcelona Clinic Liver Cancer stage B); however, it can also be utilized as a neoadjuvant treatment prior to surgical resection in resectable HCC cases. This study aimed t...

Full description

Bibliographic Details
Main Authors: Pipit Burasakarn, Sermsak Hongjinda, Anuparp Thienhiran, Nichaphat Phancharoenkit, Pusit Fuengfoo
Format: Article
Language:English
Published: Society of Gastrointestinal Intervention 2023-10-01
Series:International Journal of Gastrointestinal Intervention
Subjects:
carcinoma
hepatocellular; chemoembolization
therapeutic; general surgery; survival; treatment outcome
Online Access:https://www.ijgii.org/journal/view.html?doi=10.18528/ijgii230025

Internet

https://www.ijgii.org/journal/view.html?doi=10.18528/ijgii230025

Similar Items